Drug intelligence / Profile preview

Acacia

Development stage: Approved
Modality: Small Molecules, Microbiome Therapeutics
Administration: Oral, Topical

Overview

Acacia refers to natural products derived from trees of the Acacia genus. Primarily, Acacia gum (also known as Gum Arabic), a complex polysaccharide harvested from Acacia seyal or Acacia senegal, is a highly soluble dietary fiber. It is widely used as a food additive and dietary supplement, functioning as a prebiotic to modulate gut microbiota and influence metabolic and inflammatory markers. Another distinct product, Acacia catechu, is utilized for its antiplaque and antigingivitis properties, often in topical applications like mouthrinses or gels.

Brand names: FibregumTM
Other names: Acacia gumGum ArabicAcacia seyalAcacia senegalAcacia catechu

Targets

CAZymes (Microbial carbohydrate-active enzymes)PRR (Pattern recognition receptors)

Beyond the preview

Go deeper on Acacia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acacia.

Explore the full profile